Novel functions for Rab GTPases in multiple aspects of tumour progression

Biochemical Society Transactions

Volumn 40, Issue 6, 2012, Pages 1398-1403

  Recchi, Chiara ^a   Seabra, Miguel C ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NOVA MEDICAL SCHOOL   (Portugal)

Author keywords

Cancer; Exosome; Invasion; Migration; Rab GTPase; Tumour microenvironment

Indexed keywords

3 (3 PYRIDYL) 2 HYDROXY 2 PHOSPHONOPROPANOIC ACID; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; GELATINASE B; MULTIDRUG RESISTANCE PROTEIN; PROTEINASE; RAB PROTEIN; RAB11 PROTEIN; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL COMMUNICATION; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG TUMOR; MULTIDRUG RESISTANCE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PRENYLATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL CYCLE; CELL MOVEMENT; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84870196513     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120199     Document Type: Conference Paper

References (69)

1. Diekmann, Y., Seixas, E., Gouw, M., Tavares-Cadete, F., Seabra, M.C. and Pereira-Leal, J.B. (2011) Thousands of rab GTPases for the cell biologist. PLoS Comput. Biol. 7, e1002217
2. Stenmark, H. (2009) Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10, 513-525
3. He, H., Dai, F., Yu, L., She, X., Zhao, Y., Jiang, J., Chen, X. and Zhao, S. (2002) Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expression 10, 231-242 (Pubitemid 35315385)
4. Shimada, K., Uzawa, K., Kato, M., Endo, Y., Shiiba, M., Bukawa, H., Yokoe, H., Seki, N. and Tanzawa, H. (2005) Aberrant expression of RAB1A in human tongue cancer. Br. J. Cancer 92, 1915-1921 (Pubitemid 40826141)
5. Culine, S., Honore, N., Closson, V., Droz, J.P., Extra, J.M., Marty, M., Tavitian, A. and Olofsson, B. (1994) A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours. Eur. J. Cancer 30A, 670-674 (Pubitemid 24164257)
6. Yao, R., Wang, Y., Lubet, R.A. and You, M. (2002) Differentially expressed genes associated with mouse lung tumor progression. Oncogene 21, 5814-5821 (Pubitemid 35333016)
7. Tan, P.Y., Chang, C.W., Chng, K.R., Wansa, K.D., Sung, W.K. and Cheung, E. (2012) Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol. Cell. Biol. 32, 399-414
8. Amillet, J.M., Ferbus, D., Real, F.X., Antony, C., Muleris, M., Gress, T.M. and Goubin, G. (2006) Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma. Hum. Pathol. 37, 256-263 (Pubitemid 43277513)
9. Kotzsch, M., Sieuwerts, A.M., Grosser, M., Meye, A., Fuessel, S., Meijer-van Gelder, M.E., Smid, M., Schmitt, M., Baretton, G., Luther, T. et al. (2008) Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res. Treat. 111, 229-240
10. Luo, H., Zhang, H., Zhang, Z., Zhang, X., Ning, B., Guo, J., Nie, N., Liu, B. and Wu, X. (2009) Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res. 28, 82
11. Yang, Q., Jie, Z., Cao, H., Greenlee, A.R., Yang, C., Zou, F. and Jiang, Y. (2011) Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 32, 713-722
12. Wang, R., Wang, Z.X., Yang, J.S., Pan, X., De, W. and Chen, L.B. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30, 2644-2658
13. Tanaka, T., Arai, M., Wu, S., Kanda, T., Miyauchi, H., Imazeki, F., Matsubara, H. and Yokosuka, O. (2011) Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer. Oncol. Rep. 26, 1329-1335
14. Mori, Y., Yin, J., Sato, F., Sterian, A., Simms, L.A., Selaru, F.M., Schulmann, K., Xu, Y., Olaru, A., Wang, S. et al. (2004) Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res. 64, 2434-2438 (Pubitemid 38523897)
15. Shibata, D., Mori, Y., Cai, K., Zhang, L., Yin, J., Elahi, A., Hamelin, R., Wong, Y.F., Lo, W.K., Chung, T.K. et al. (2006) RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas. Int. J. Cancer 119, 801-806 (Pubitemid 44051442)
16. Wu, C.Y., Tseng, R.C., Hsu, H.S., Wang, Y.C. and Hsu, M.T. (2009) Frequent down-regulation of hRAB37 in metastatic tumor by genetic and epigenetic mechanisms in lung cancer. Lung Cancer 63, 360-367
17. Mueller, D.W., Rehli, M. and Bosserhoff, A.K. (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J. Invest. Dermatol. 129, 1740-1751
18. Ho, J.R., Chapeaublanc, E., Kirkwood, L., Nicolle, R., Benhamou, S., Lebret, T., Allory, Y., Southgate, J., Radvanyi, F. and Goud, B. (2012) Deregulation of rab and rab effector genes in bladder cancer. PLoS ONE 7, e39469
19. Yoon, S.O., Shin, S. and Mercurio, A.M. (2005) Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the α6β4 integrin. Cancer Res. 65, 2761-2769 (Pubitemid 40490078)
20. Cheng, K.W., Lahad, J.P., Kuo, W.L., Lapuk, A., Yamada, K., Auersperg, N., Liu, J., Smith-McCune, K., Lu, K.H., Fishman, D. et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10, 1251-1256 (Pubitemid 39540444)
21. Caswell, P.T., Spence, H.J., Parsons, M., White, D.P., Clark, K., Cheng, K.W., Mills, G.B., Humphries, M.J., Messent, A.J., Anderson, K.I. et al. (2007) Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell 13, 496-510 (Pubitemid 47514517)
22. Dozynkiewicz, M.A., Jamieson, N.B., Macpherson, I., Grindlay, J., van den Berghe, P.V., von Thun, A., Morton, J.P., Gourley, C., Timpson, P., Nixon, C. et al. (2012) Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev. Cell 22, 131-145
23. Caswell, P.T., Chan, M., Lindsay, A.J., McCaffrey, M.W., Boettiger, D. and Norman, J.C. (2008) Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 183, 143-155
24. Zhang, J., Liu, X., Datta, A., Govindarajan, K., Tam, W.L., Han, J., George, J., Wong, C., Ramnarayanan, K., Phua, T.Y. et al. (2009) RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest. 119, 2171-2183
25. Muller, P.A., Caswell, P.T., Doyle, B., Iwanicki, M.P., Tan, E.H., Karim, S., Lukashchuk, N., Gillespie, D.A., Ludwig, R.L., Gosselin, P. et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139, 1327-1341
26. Goldenring, J.R. and Nam, K.T. (2011) Rab25 as a tumour suppressor in colon carcinogenesis. Br. J. Cancer 104, 33-36
27. Nam, K.T., Lee, H.J., Smith, J.J., Lapierre, L.A., Kamath, V.P., Chen, X., Aronow, B.J., Yeatman, T.J., Bhartur, S.G., Calhoun, B.C. et al. (2011) Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J. Clin. Invest. 120, 840-849
28. Cheng, J.M., Ding, M., Aribi, A., Shah, P. and Rao, K. (2006) Loss of RAB25 expression in breast cancer. Int. J. Cancer 118, 2957-2964
29. Cheng, J.M., Volk, L., Janaki, D.K., Vyakaranam, S., Ran, S. and Rao, K.A. (2009) Tumor suppressor function of Rab25 in triple negative breast cancer. Int. J. Cancer 126, 2799-2812
30. Pellinen, T., Arjonen, A., Vuoriluoto, K., Kallio, K., Fransen, J.A. and Ivaska, J. (2006) Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins. J. Cell Biol. 173, 767-780 (Pubitemid 46165584)
31. Torres, V.A., Mielgo, A., Barbero, S., Hsiao, R., Wilkins, J.A. and Stupack, D.G. (2010) Rab5 mediates caspase-8-promoted cell motility and metastasis. Mol. Biol. Cell 21, 369-376
32. Yang, P.S., Yin, P.H., Tseng, L.M., Yang, C.H., Hsu, C.Y., Lee, M.Y., Horng, C.F. and Chi, C.W. (2011) Rab5A is associated with axillary lymph node metastasis in breast cancer patients. Cancer Sci. 102, 2172-2178
33. Liu, S.S., Chen, X.M., Zheng, H.X., Shi, S.L. and Li, Y. (2011) Knockdown of Rab5a expression decreases cancer cell motility and invasion through integrin-mediated signaling pathway. J. Biomed. Sci. 18, 58
34. Fukui, K., Tamura, S., Wada, A., Kamada, Y., Igura, T., Kiso, S. and Hayashi, N. (2007) Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol. Res. 37, 957-965 (Pubitemid 47399925)
35. Bravo-Cordero, J.J., Marrero-Diaz, R., Megias, D., Genis, L., Garcia-Grande, A., Garcia, M.A., Arroyo, A.G. and Montoya, M.C. (2007) MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 26, 1499-1510 (Pubitemid 46480932)
36. Williams, K.C. and Coppolino, M.G. (2011) Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration. J. Biol. Chem. 286, 43405-43416
37. Hendrix, A., Maynard, D., Pauwels, P., Braems, G., Denys, H., Van den Broecke, R., Lambert, J., Van Belle, S., Cocquyt, V., Gespach, C. et al. (2010) The secretory small GTPase Rab27B regulates invasive tumor growth and metastasis through extracellular HSP90α. J. Natl. Cancer Inst. 102, 866-880
38. Montel, V., Huang, T.Y., Mose, E., Pestonjamasp, K. and Tarin, D. (2005) Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol. 166, 1565-1579 (Pubitemid 40586524)
39. Dong, W.W., Mou, Q., Chen, J., Cui, J.T., Li, W.M. and Xiao, W.H. (2012) Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J. Gastroenterol. 18, 1806-1813
40. Wang, J.S., Wang, F.B., Zhang, Q.G., Shen, Z.Z. and Shao, Z.M. (2008) Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol. Cancer Res. 6, 372-382
41. Brobrie, A., Krumeich, S., Reyal, F., Recchi, C., Moita, L.F., Seabra, M.C., Ostrowski, M. and Thery, C. (2012) Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 72, 4920-4930
42. Barbarin, A. and Frade, R. (2011) Procathepsin L secretion, which triggers tumour progression, is regulated by Rab4a in human melanoma cells. Biochem. J. 437, 97-107
43. Cirri, P. and Chiarugi, P. (2012) Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195-208
44. Hooper, S., Gaggioli, C. and Sahai, E. (2010) A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion. Br. J. Cancer 102, 392-402
45. Iero, M., Valenti, R., Huber, V., Filipazzi, P., Parmiani, G., Fais, S. and Rivoltini, L. (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15, 80-88 (Pubitemid 350286175)
46. Ostrowski, M., Carmo, N.B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C.F., Schauer, K., Hume, A.N., Freitas, R.P. et al. (2009) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19-30
47. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C.M. et al. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891
48. Akavia, U.D., Litvin, O., Kim, J., Sanchez-Garcia, F., Kotliar, D., Causton, H.C., Pochanard, P., Mozes, E., Garraway, L.A. and Pe'er, D. (2010) An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017
49. Young, J., Menetrey, J. and Goud, B. (2010) RAB6C is a retrogene that encodes a centrosomal protein involved in cell cycle progression. J. Mol. Biol. 397, 69-88
50. Pellinen, T., Tuomi, S., Arjonen, A., Wolf, M., Edgren, H., Meyer, H., Grosse, R., Kitzing, T., Rantala, J.K., Kallioniemi, O. et al. (2008) Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev. Cell 15, 371-385
51. Eggenschwiler, J.T., Espinoza, E. and Anderson, K.V. (2001) Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature 412, 194-198 (Pubitemid 32674717)
52. Chi, S., Xie, G., Liu, H., Chen, K., Zhang, X., Li, C. and Xie, J. (2012) Rab23 negatively regulates Gli1 transcriptional factor in a Su(Fu)-dependent manner. Cell. Signalling 24, 1222-1228
53. Hou, Q., Wu, Y.H., Grabsch, H., Zhu, Y., Leong, S.H., Ganesan, K., Cross, D., Tan, L.K., Tao, J., Gopalakrishnan, V. et al. (2008) Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res. 68, 4623-4630
54. Liu, Y.J., Wang, Q., Li, W., Huang, X.H., Zhen, M.C., Huang, S.H., Chen, L.Z., Xue, L. and Zhang, H.W. (2007) Rab23 is a potential biological target for treating hepatocellular carcinoma. World J. Gastroenterol. 13, 1010-1017 (Pubitemid 46511001)
55. Fu, D. and Arias, I.M. (2012) Intracellular trafficking of P-glycoprotein. Int. J. Biochem. Cell Biol. 44, 461-464
56. Ferrandiz-Huertas, C., Fernandez-Carvajal, A. and Ferrer-Montiel, A. (2011) Rab4 interacts with the human P-glycoprotein and modulates its surface expression in multidrug resistant K562 cells. Int. J. Cancer 128, 192-205
57. Shan, J., Mason, J.M., Yuan, L., Barcia, M., Porti, D., Calabro, A., Budman, D., Vinciguerra, V. and Xu, H. (2000) Rab6c, a new member of the rab gene family, is involved in drug resistance in MCF7/AdrR cells. Gene 257, 67-75
58. Shen, D.W. and Gottesman, M.M. (2012) RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm. Res. 29, 643-650
59. Pei, L., Peng, Y., Yang, Y., Ling, X.B., Van Eyndhoven, W.G., Nguyen, K.C., Rubin, M., Hoey, T., Powers, S. and Li, J. (2002) PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. Cancer Res. 62, 5420-5424
60. Chamberlain, M.D., Chan, T., Oberg, J.C., Hawrysh, A.D., James, K.M., Saxena, A., Xiang, J. and Anderson, D.H. (2008) Disrupted RabGAP function of the p85 subunit of phosphatidylinositol 3-kinase results in cell transformation. J. Biol. Chem. 283, 15861-15868
61. Sato, N., Koinuma, J., Ito, T., Tsuchiya, E., Kondo, S., Nakamura, Y. and Daigo, Y. (2010) Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer 49, 353-367
62. Detter, J.C., Zhang, Q., Mules, E.H., Novak, E.K., Mishra, V.S., Li, W., McMurtrie, E.B., Tchernev, V.T., Wallace, M.R., Seabra, M.C. et al. (2000) Rab geranylgeranyl transferase α mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc. Natl. Acad. Sci. U.S.A. 97, 4144-4149 (Pubitemid 30226101)
63. Lackner, M.R., Kindt, R.M., Carroll, P.M., Brown, K., Cancilla, M.R., Chen, C., de Silva, H., Franke, Y., Guan, B., Heuer, T. et al. (2005) Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors. Cancer Cell 7, 325-336 (Pubitemid 40544650)
64. Coxon, F.P., Helfrich, M.H., Larijani, B., Muzylak, M., Dunford, J.E., Marshall, D., McKinnon, A.D., Nesbitt, S.A., Horton, M.A., Seabra, M.C. et al. (2001) Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J. Biol. Chem. 276, 48213-48222
65. Roelofs, A.J., Hulley, P.A., Meijer, A., Ebetino, F.H., Russell, R.G. and Shipman, C.M. (2006) Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells. Int. J. Cancer 119, 1254-1261 (Pubitemid 44258797)
66. Lawson, M.A., Coulton, L., Ebetino, F.H., Vanderkerken, K. and Croucher, P.I. (2008) Geranylgeranyl transferase type II inhibition prevents myeloma bone disease. Biochem. Biophys. Res. Commun. 377, 453-457
67. Boissier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F.H., Colombel, M., Delmas, P., Delaisse, J.M. and Clezardin, P. (2000) Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res. 60, 2949-2954 (Pubitemid 30395820)
68. Fournier, P.G., Daubine, F., Lundy, M.W., Rogers, M.J., Ebetino, F.H. and Clezardin, P. (2008) Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. Cancer Res. 68, 8945-8953
69. Seabra, M.C., Mules, E.H. and Hume, A.N. (2002) Rab GTPases, intracellular traffic and disease. Trends Mol. Med. 8, 23-30 (Pubitemid 34044675)